Trading Members of the Exchange are hereby informed that effective from Wednesday, May 04, 2022, the Equity Shares of Global Longlife Hospital and Research Limited shall be listed and admitted to dealings on the Exchange in the list of 'MT' Group of Securities. Further in terms of SEBI circular No. CIR/MRD/DP/02/2012 dated January 20, 2012; the scrip will be in Trade-for-Trade segment for 10 trading days
Name of the company
|
Global Longlife Hospital and Research Limited
|
Registered Office:
|
Global Hospital, Opp. Auda Garden,
Nr. Water Tank, Bodakdev,
Ahmedabad - 380054, Gujarat, India
Tel : 079-29700082
Email :investor@globalhospital.co.in
Website :www.globalhospital.co.in
|
No. of Securities
|
1,05,00,000 Equity Shares Of Rs.10/- each fully paid up
|
Distinctive Number range
|
1 To 1, 05,00,000
|
Scrip ID on BOLT System
|
GLHRL
|
Abbreviated Name on BOLT System
|
GLHRL
|
Scrip Code
|
543520
|
ISIN No.
|
INE0J2K01014
|
Market Lot
|
1000
|
Issue Price for the current Public issue
|
Rs. 140/- per share (Face Value of Rs. 10/- and premium of Rs. 130/-)
|
Date of Allotment in the public issue:
|
April 28, 2022
|
Pari Pasu
|
Yes
|
Financial Year
|
March-31
|
Lock in detail
|
As per Annexure I
|
Shareholding Pattern
|
As per Annexure II
|
a) Trading Members may note that as per the guidelines issued by SEBI dated 16th February 2000, securities of the Company will only be traded in Dematerialized form. Trades effected in this scrip will be in minimum market lot (i.e., 1000 equity shares) and the same shall be modified by the Exchange from time to time by giving prior market notice of at least one month
b) Further the trading members may please note that the above mentioned scrip will be a part of Special Pre-open Session (SPOS) on Wednesday, May 4, 2022. For further information on SPOS, the trading members are requested to refer to the Exchanges notice no. 20120216-29 dated February 16, 2012 on Enabling Special Pre-open Session for IPOs & Relisted Scrips.
c) The company has informed the Exchange that in respect of shares in physical form, the respective share certificates have been enfaced with their non-transferability. The company has informed the Exchange that in respect of shares in demat form, necessary corporate action has been executed to have the lock-in period marked in the depositorys records.
d) The Market Maker to the issue as mentioned in the prospectus is given below:
Rikhav Securities Limited
B, Matruchhaya, 4th floor, S.N. Road,
Mulund (W), Mumbai- 80
Tel No: 022-25935353
Email: info@rikhav.net
Website: www.rikhav.net
Contact Person: Mr. Hitesh Lakhani
SEBI Registration No: INZ00157737
|
e) The Registrar to the issue as mentioned in the prospectus is given below
BIGSHARE SERVICES PRIVATE LIMITED
1st Floor, Bharat Tin works Building, Opp. Vasant Oasis,
Makwana Road, Marol, Andheri East, Mumbai-400059
Tel No:+91 22-62638200
Fax No +91 22-62638299
Website: www.bigshareonline.com
E-Mail: ipo@bigshareonline.com
Investor Grievance Email: investor@bigshareonline.com
Contact Person: Mr. Swapnil Kate
SEBI Reg. No.: INR000001385
|
f) In case members require any clarifications on the subject matter of this notice, they may please contact any of the following:
a) At the company:
Mr. Deepak Ravidatta Sharma,
Company Secretary and Compliance Officer
|
Address:
Global Hospital, Opp. Auda Garden,
Nr. Water Tank, Bodakdev,
Ahmedabad - 380054, Gujarat, India
Tel : 079-29700082
Email :investor@globalhospital.co.in
Website :www.globalhospital.co.in
|
b) At the Exchange:
Raghavendra Bhat
Deputy Manager
|
Tel.: (91) 022 2272 8915
|
Rupal Khandelwal
Assistant General Manager
Monday, May 2,2022 |